the role of bispecific antibodies in the treatment of r/r large b-cell lymphoma
Published 1 year ago • 122 plays • Length 1:15Download video MP4
Download video MP3
Similar videos
-
2:39
the role of bispecific antibodies in the treatment landscape for r/r dlbcl
-
1:56
the future of bispecific antibodies in the treatment and management of r/r follicular lymphoma
-
1:30
bispecific antibodies for r/r aggressive b-cell lymphomas
-
1:54
the important role of bispecific antibodies in the future treatment of r/r dlbcl
-
1:48
the potential of bispecific antibody-containing combinations in patients with b-cell lymphomas
-
1:17
the promise of bispecific antibodies in the treatment of nhl
-
2:33
the role of bispecific antibodies in the treatment of patients with multiple myeloma
-
2:39
advancements in bispecific and trispecific antibodies for the treatment of lymphoma
-
6:24
tnb-486: interim results of a cd19/cd3 t-cell engager in r/r follicular lymphoma
-
3:13
advances in medical devices and their impact on drug delivery
-
6:25
novel tools to monitor the immune system in lymphoma clinical trials
-
2:36
a cd38-targeting bispecific antibody in the treatment of r/r t-all
-
2:05
clinical guidance for the use of bispecific antibodies in nhl
-
3:12
the role of bispecific antibodies in r/r nhl: the biology of these agents and what the future holds
-
3:20
bispecific antibodies in nhl: current insights and ongoing studies
-
1:36
the changing role of chemotherapy in lymphoma and the value of novel immunotherapies
-
1:21
cd20/cd3 bispecific antibodies in r/r dlbcl: glofitamab and epcoritamab
-
4:02
an overview of bispecifics in r/r myeloma and their integration into the treatment landscape
-
1:22
first-in-human study of tg-1801, a cd19/cd47 bispecific antibody ± ublituximab in bcl
-
2:04
an insight into how bispecifics are changing the lymphoma treatment landscape
-
2:30
vipor regimen for r/r b-cell lymphoma
-
0:58
first-in-human trial of cln-978, a novel cd19 bispecific antibody, for the treatment of r/r b-nhl